Edition:
United Kingdom

CanniMed Therapeutics Inc (CMED.TO)

CMED.TO on Toronto Stock Exchange

30.77CAD
23 Apr 2018
Change (% chg)

$-2.03 (-6.19%)
Prev Close
$32.80
Open
$32.81
Day's High
$32.81
Day's Low
$30.77
Volume
13,755
Avg. Vol
384,843
52-wk High
$46.00
52-wk Low
$7.32

Chart for

About

CanniMed Therapeutics Inc is a Canada-based plant biopharmaceutical company. It is specialized in the production of pharmaceutical-grade cannabis and offers a range of pharmaceutical-grade cannabis products. In addition, the Company has a plant biotechnology research and product development program focused on the production of... (more)

Overall

Beta: --
Market Cap(Mil.): $261.62
Shares Outstanding(Mil.): 22.67
Dividend: --
Yield (%): --

Financials

  CMED.TO Industry Sector
P/E (TTM): -- 30.95 32.74
EPS (TTM): -1.12 -- --
ROI: -22.66 14.84 14.38
ROE: -28.19 16.34 16.07

Pot producer Aurora gets final regulatory nod for CanniMed purchase

Canada's No.2 marijuana producer Aurora Cannabis Inc on Wednesday received final regulatory approval for the purchase of smaller rival CanniMed Therapeutics Inc , which would make it the world's most valuable weed producer.

28 Feb 2018

Pot producer Aurora gets final regulatory nod for CanniMed purchase

Feb 28 Canada's No.2 marijuana producer Aurora Cannabis Inc on Wednesday received final regulatory approval for the purchase of smaller rival CanniMed Therapeutics Inc, which would make it the world's most valuable weed producer.

28 Feb 2018

BRIEF-Aurora Cannabis Announces Receipt Of Final Regulatory Approval For CanniMed Therapeutics Acquisition

* AURORA CANNABIS ANNOUNCES RECEIPT OF FINAL REGULATORY APPROVAL FOR CANNIMED THERAPEUTICS ACQUISITION AND ITS INTENTION TO TAKE-UP AS SOON AS MINIMUM TENDER CONDITION IS MET

28 Feb 2018

BRIEF-Aurora Cannabis And Cannimed Therapeutics File Offer Documents For Previously Announced Friendly Acquisition

* AURORA CANNABIS AND CANNIMED THERAPEUTICS FILE OFFER DOCUMENTS FOR PREVIOUSLY ANNOUNCED FRIENDLY ACQUISITION Source text for Eikon: Further company coverage:

06 Feb 2018

CANADA STOCKS-Toronto shares hit six-week low as resources drag

Jan 29 Canada's main stock index fell on Monday, touching a six-week low as energy and other resource shares tumbled alongside commodity prices.

29 Jan 2018

UPDATE 4-Canada's Aurora Cannabis to buy rival to create world's most valuable weed firm

Jan 24 Canada's No. 2 marijuana producer Aurora Cannabis Inc has agreed to buy smaller rival CanniMed Therapeutics Inc for C$1.1 billion ($852 million) as companies jostle to benefit from the country's legalization of recreational marijuana use later this year.

24 Jan 2018

FACTBOX-World's biggest marijuana M&A, stake purchase deals

Jan 24 Canada's second-biggest marijuana producer Aurora Cannabis Inc has agreed to buy smaller rival CanniMed Therapeutics Inc for C$1.1 billion ($852 million), creating the world's largest weed producer by market value. The agreement topped global cannabis merger and acquisition activity, pushing deal values so far in 2018 to far above those in entire previous years. It brought the total value of marijuana-related mergers and acquisitions to $1.2 billion so far in 2018, mo

24 Jan 2018

BRIEF-Aurora Cannabis, Cannimed Therapeutics Agree To Terms On Friendly Transaction

* AURORA CANNABIS AND CANNIMED THERAPEUTICS AGREE TO TERMS ON FRIENDLY TRANSACTION

24 Jan 2018

Cannabis producer Aurora to buy CanniMed for C$1.1 bln

Jan 24 Canadian marijuana producer Aurora Cannabis on Wednesday agreed to buy CanniMed Therapeutics Inc for about C$1.1 billion ($892.21 million), gearing up to meet an expected surge in demand at home and globally.

24 Jan 2018

BRIEF-CanniMed Therapeutics Announces Continued Discussions With Aurora

* CANNIMED THERAPEUTICS ANNOUNCES CONTINUED DISCUSSIONS WITH AURORA

23 Jan 2018

Earnings vs. Estimates